title: Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
abstract: We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization program. In our study, the pediatric two-dose regimen of VAQTA was found to be generally well tolerated and resulted in 100% (95% CI 94.8, 100.0) seroconversion after 2 doses. Immunizing children with the HAV vaccine routinely should be considered in South Korea, particularly in areas where recent outbreaks have occurred.
authors.affiliation: Department of Pediatrics, Yongdong Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. ymsohn@navekids.co.kr
authors.forename: Y M
authors.initials: YM
authors.lastname: Sohn
authors.forename: J S
authors.initials: JS
authors.lastname: Lee
authors.forename: J H
authors.initials: JH
authors.lastname: Park
authors.forename: G
authors.initials: G
authors.lastname: Poerschke
authors.forename: K
authors.initials: K
authors.lastname: Eves
authors.forename: J
authors.initials: J
authors.lastname: Gress
authors.forename: B
authors.initials: B
authors.lastname: Kuter
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control*; D004334:Drug Administration Schedule; D005260:Female; D006506:Hepatitis A / Q000517:prevention & control*; D022362:Hepatitis A Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D017589:Immunization Programs; D007723:Korea; D008297:Male
chemical_list: D022362:Hepatitis A Vaccines